We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.07B
AUM Growth
-$11.6M
(-0.23%)
Cap. Flow
-$144M
Cap. Flow
% of AUM
-2.83%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
159
New
22
Increased
53
Reduced
27
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$48.3M |
| 2 |
Flywire
FLYW
|
+$47.9M |
| 3 |
dLocal
DLO
|
+$36.1M |
| 4 |
DoubleVerify
DV
|
+$35.7M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$31.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cintas
CTAS
|
+$108M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$106M |
| 3 |
Biohaven
BHVN
|
+$74.9M |
| 4 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$68M |
| 5 |
MongoDB
MDB
|
+$57.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.02% |
| 2 | Technology | 23.53% |
| 3 | Industrials | 12.87% |
| 4 | Consumer Discretionary | 5.44% |
| 5 | Utilities | 4.36% |
Similar funds
HPG
EMPI
RCG
JWBC
AAM
AA
CM
CIS
Eventide Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Eventide Asset Management held 159 positions worth $5.07B, down 0.23% from $5.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Eventide Asset Management's Q4 2022 filing shows 22 new, 53 increased, 27 reduced and 17 closed positions. Its largest new stake was Seagen Inc. Common Stock: 242,545 shares worth $31.2M. The largest sale was Cintas, an estimated $108M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.
- Eventide Asset Management's largest Q4 2022 buy was Seagen Inc. Common Stock: 242,545 shares worth $31.2M.
- Eventide Asset Management added most to Evolent Health in Q4 2022, an estimated $48.3M increase.
- Eventide Asset Management's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $106M.
- Eventide Asset Management fully exited Cintas in Q4 2022, selling an estimated $108M.
- Eventide Asset Management's ten largest holdings make up 25% of its $5.07B portfolio in Q4 2022.
- Eventide Asset Management opened 22 new positions and closed 17 in Q4 2022.
- Eventide Asset Management's portfolio value fell 0.23% quarter-over-quarter to $5.07B.
Based on Eventide Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.